DE602004031088D1 - Mutierte SREBP-1c Promoteren und deren Verwendung - Google Patents

Mutierte SREBP-1c Promoteren und deren Verwendung

Info

Publication number
DE602004031088D1
DE602004031088D1 DE602004031088T DE602004031088T DE602004031088D1 DE 602004031088 D1 DE602004031088 D1 DE 602004031088D1 DE 602004031088 T DE602004031088 T DE 602004031088T DE 602004031088 T DE602004031088 T DE 602004031088T DE 602004031088 D1 DE602004031088 D1 DE 602004031088D1
Authority
DE
Germany
Prior art keywords
srebp
promoters
mutant
metabolic disorder
inactivated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004031088T
Other languages
English (en)
Inventor
Yoshihiko Nishio
Hiroshi Maegawa
Atsunori Kashiwagi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Publication of DE602004031088D1 publication Critical patent/DE602004031088D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0362—Animal model for lipid/glucose metabolism, e.g. obesity, type-2 diabetes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE602004031088T 2003-02-20 2004-02-19 Mutierte SREBP-1c Promoteren und deren Verwendung Expired - Lifetime DE602004031088D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003043398 2003-02-20
JP2003160856 2003-06-05
PCT/JP2004/001924 WO2004074475A1 (ja) 2003-02-20 2004-02-19 転写制御シスエレメント及びそれに特異的に結合する転写調節因子並びにそれらの用途

Publications (1)

Publication Number Publication Date
DE602004031088D1 true DE602004031088D1 (de) 2011-03-03

Family

ID=32911421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004031088T Expired - Lifetime DE602004031088D1 (de) 2003-02-20 2004-02-19 Mutierte SREBP-1c Promoteren und deren Verwendung

Country Status (5)

Country Link
US (1) US20070032643A1 (de)
EP (1) EP1600507B1 (de)
AT (1) ATE496126T1 (de)
DE (1) DE602004031088D1 (de)
WO (1) WO2004074475A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0304860A (pt) * 2002-11-11 2004-08-31 Ajinomoto Kk Método para produzir uma substância alvo pela utilização de uma-bactéria pertencente ao gênero escherichia
CN104946579A (zh) * 2015-07-03 2015-09-30 浙江大学 一种金华猪乳腺上皮细胞系的培养方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224515A1 (en) * 2002-06-04 2003-12-04 Isis Pharmaceuticals Inc. Antisense modulation of sterol regulatory element-binding protein-1 expression

Also Published As

Publication number Publication date
EP1600507A4 (de) 2006-07-19
EP1600507A1 (de) 2005-11-30
US20070032643A1 (en) 2007-02-08
EP1600507B1 (de) 2011-01-19
ATE496126T1 (de) 2011-02-15
WO2004074475A1 (ja) 2004-09-02

Similar Documents

Publication Publication Date Title
ATE423571T1 (de) Verwendung von bispezifischen antikörpern gegen einen aktivierenden rezeptor fcepsilonri und gegen einen inhibierenden rezeptor ox2ra (cd200ra) zur regulierung der immunantworten
ATE541859T1 (de) Humane anti-interferon-gamma-antikörper und verfahren zu ihrer verwendung
ATE496636T1 (de) Verwendung von agonisten und antagonisten von interleukin-33 (il-33)
MX2021000858A (es) Animales no humanos geneticamente modificados que expresan eritropoyetina de humano.
DK1660057T3 (da) Kombinationsterapi til behandling af neovaskulære øjenlidelser
DE602007000788D1 (de) Vielblattkollimator und Strahlentherapieanlage
DE60324219D1 (de) Elektrophotographisches, lichtempfindliches Element, Prozesskartusche und elektrophotographischer Apparat
DE602004002147D1 (de) Apparat für kardiopulmonäre Reanimation mit Feedback von Messungen des Pulses und/oder des Sauerstoffgehalts des Blutes
NO20052541D0 (no) Anordning for lateral styring av streamerkabler samt fremgangsmate for samme.
WO2007033290A3 (en) Optical vestibular stimulator
ATE555653T1 (de) Tierhaltungssysteme und bestandteile für die tierhaltung
AU4929701A (en) Whole-body optical imaging of gene expression and uses thereof
CY2014007I2 (el) Μεθοδοι για την αγωγη διαταραχων ή παθησεων που συσχετιζονται με υπερλιπιδαιμια και υπερχοληστερολαιμια ενω ελαχιστοποιουνται οι παρενεργειες
BR0300035B1 (pt) sistema para otimizar uma prescriÇço para um tratamento refrativo.
DE602005020397D1 (de) Optische Rastervorrichtung mit Korrektur der Aberrationen und bilderzeugender Apparat unter Verwendung derselben
DE60336068D1 (de) Antikörper gerichtet gegen oxidierten Apolipoprotein B
DE602004031088D1 (de) Mutierte SREBP-1c Promoteren und deren Verwendung
DE602004021214D1 (de) Regelstrecke mit Kompensation von Störgrössen
BR0313588A (pt) Métodos para o tratamento da demência com base em apo e genótipo
DE602004031820D1 (de) Toner mit Steuermittel für negative Ladung und Verwendung von Polykondensationsprodukten als Ladungssteuermittel
ATE445592T1 (de) Derivate von heteroarylalkylcarbamaten, verfahren zu deren herstellung und deren verwendung als faah-enzyminhibitoren
ATE494551T1 (de) C20orf23 als modifikator des igfr-wegs und verwendungsverfahren
DE602007010268D1 (de) Diagnostikum und therapeutikum gegen bauchspeicheldrüsenkrebs
ATE372990T1 (de) Oxazolderivat und deren verwendung als insulinsensibilisatoren
DE59308875D1 (de) Monoklonaler Anti-Gangliosid-Antikörper, seine Herstellung und Verwendung als Tumortherapeutikum